A PHASE 2/3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Administered By

Pediatrics, Nephrology

Awarded By

Reata Pharmaceuticals, Inc.

Contributors

Gbadegesin, Rasheed Adebayo Principal Investigator

Start/End

January 5, 2018 - December 31, 2020